Edition:
United States

GTX Inc (GTXI.OQ)

GTXI.OQ on NASDAQ Stock Exchange Capital Market

17.39USD
23 Apr 2018
Change (% chg)

$0.27 (+1.58%)
Prev Close
$17.12
Open
$17.08
Day's High
$17.56
Day's Low
$16.49
Volume
34,060
Avg. Vol
26,854
52-wk High
$23.36
52-wk Low
$2.77

Select another date:

Mon, Apr 9 2018

BRIEF-GTX Announces Early Completion Of Patient Enrollment In The Astrid Trial

* GTX ANNOUNCES EARLY COMPLETION OF PATIENT ENROLLMENT IN THE ASTRID TRIAL, A PHASE 2 CLINICAL TRIAL OF ENOBOSARM IN STRESS URINARY INCONTINENCE

BRIEF-GTX Inc Q4 Loss Per Share $0.43

* GTX PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-GTx Announced New Data Demonstrating Enobosarm's Potential To Treat Stress Urinary Incontinence At SUFU 2018

* GTX ANNOUNCED NEW DATA DEMONSTRATING ENOBOSARM’S POTENTIAL TO TREAT STRESS URINARY INCONTINENCE AT SUFU 2018

BRIEF-GTx Trial Results In Stress Urinary Incontinence Accepted For Podium Presentation At SUFU

* GTX PHASE 2 ENOBOSARM CLINICAL TRIAL RESULTS IN STRESS URINARY INCONTINENCE ACCEPTED FOR PODIUM PRESENTATION AT SUFU Source text for Eikon: Further company coverage:

BRIEF-GTX Inc Files For Mixed Shelf Offering Of Up To $150 Mln

* GTX INC FILES FOR MIXED SHELF OFFERING OF UP TO $150 MILLION - SEC FILING Source text: (http://bit.ly/2kHuojK) Further company coverage:

BRIEF-GTX reports qtrly ‍loss per share $0.53​

* GTX provides corporate update and reports third quarter 2017 financial results

Select another date: